TabsDetailsBasic DetailsDate: Monday, September 14, 2015Type: PublicationMedical Product: 13-valent pneumococcal vaccine (PCV13), trivalent inactivated influenza vaccine (TIV)Health Outcome(s): febrile seizureMaterials: Pediatrics peds.2015-0635; published ahead of print September 14, 2015, doi:10.1542/peds.2015-0635Additional InformationInformationTime Period: 2010–2011 influenza seasonRelated Assessment(s): Influenza Vaccines and Febrile Seizures (PRISM)ContributorsAuthor(s): Alison Tse Kawai ScD; David Martin MD, MPH; Martin Kulldorff PhD; Lingling Li PhD; David V. Cole BM; Cheryl N. McMahill-Walraven PhD, MSW; Nandini Selvam PhD, MPH; Mano S. Selvan PhD; Grace M. Lee MD, MPHCorresponding Author: A. T. Kawai, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts. Email: alison_kawai@harvardpilgrim.org
